Marel hf (MAREL.AS) Fundamental Analysis & Valuation

AMS:MARELIS0000000388

Current stock price

4.55 EUR
+0.12 (+2.71%)
Last:

This MAREL.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. MAREL.AS Profitability Analysis

1.1 Basic Checks

  • In the past year MAREL was profitable.
  • In the past year MAREL had a positive cash flow from operations.
  • In the past 5 years MAREL has always been profitable.
  • MAREL had a positive operating cash flow in each of the past 5 years.
MAREL.AS Yearly Net Income VS EBIT VS OCF VS FCFMAREL.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

1.2 Ratios

  • The Return On Assets of MAREL (0.44%) is worse than 63.37% of its industry peers.
  • MAREL has a worse Return On Equity (1.10%) than 61.39% of its industry peers.
  • With a Return On Invested Capital value of 3.55%, MAREL is not doing good in the industry: 63.37% of the companies in the same industry are doing better.
  • MAREL had an Average Return On Invested Capital over the past 3 years of 5.23%. This is below the industry average of 8.62%.
Industry RankSector Rank
ROA 0.44%
ROE 1.1%
ROIC 3.55%
ROA(3y)2.73%
ROA(5y)3.95%
ROE(3y)6.07%
ROE(5y)8.09%
ROIC(3y)5.23%
ROIC(5y)6.94%
MAREL.AS Yearly ROA, ROE, ROICMAREL.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

  • MAREL's Profit Margin of 0.69% is on the low side compared to the rest of the industry. MAREL is outperformed by 62.38% of its industry peers.
  • MAREL's Profit Margin has declined in the last couple of years.
  • MAREL has a Operating Margin (5.21%) which is in line with its industry peers.
  • MAREL's Operating Margin has declined in the last couple of years.
  • The Gross Margin of MAREL (36.06%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of MAREL has declined.
Industry RankSector Rank
OM 5.21%
PM (TTM) 0.69%
GM 36.06%
OM growth 3Y-23.73%
OM growth 5Y-17.24%
PM growth 3Y-39.86%
PM growth 5Y-29.33%
GM growth 3Y-2.31%
GM growth 5Y-2.35%
MAREL.AS Yearly Profit, Operating, Gross MarginsMAREL.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

2

2. MAREL.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MAREL is destroying value.
  • MAREL has about the same amout of shares outstanding than it did 1 year ago.
  • MAREL has about the same debt/assets ratio as last year.
MAREL.AS Yearly Shares OutstandingMAREL.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M
MAREL.AS Yearly Total Debt VS Total AssetsMAREL.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 2.59 indicates that MAREL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • MAREL has a Altman-Z score of 2.59. This is in the better half of the industry: MAREL outperforms 64.36% of its industry peers.
  • MAREL has a debt to FCF ratio of 17.03. This is a negative value and a sign of low solvency as MAREL would need 17.03 years to pay back of all of its debts.
  • MAREL has a worse Debt to FCF ratio (17.03) than 63.37% of its industry peers.
  • MAREL has a Debt/Equity ratio of 0.84. This is a neutral value indicating MAREL is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.84, MAREL is doing worse than 70.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.03
Altman-Z 2.59
ROIC/WACC0.64
WACC5.55%
MAREL.AS Yearly LT Debt VS Equity VS FCFMAREL.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • MAREL has a Current Ratio of 1.36. This is a normal value and indicates that MAREL is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of MAREL (1.36) is worse than 65.35% of its industry peers.
  • MAREL has a Quick Ratio of 1.36. This is a bad value and indicates that MAREL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of MAREL (0.77) is worse than 69.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.77
MAREL.AS Yearly Current Assets VS Current LiabilitesMAREL.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

3

3. MAREL.AS Growth Analysis

3.1 Past

  • MAREL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.06%.
  • The earnings per share for MAREL have been decreasing by -25.45% on average. This is quite bad
  • MAREL shows a decrease in Revenue. In the last year, the revenue decreased by -5.67%.
  • MAREL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.52% yearly.
EPS 1Y (TTM)-72.06%
EPS 3Y-32.75%
EPS 5Y-25.45%
EPS Q2Q%-62.39%
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y11.62%
Revenue growth 5Y7.52%
Sales Q2Q%-4.14%

3.2 Future

  • MAREL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.00% yearly.
  • MAREL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.44% yearly.
EPS Next Y45.24%
EPS Next 2Y45.57%
EPS Next 3Y39%
EPS Next 5YN/A
Revenue Next Year-0.68%
Revenue Next 2Y2.53%
Revenue Next 3Y3.66%
Revenue Next 5Y4.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MAREL.AS Yearly Revenue VS EstimatesMAREL.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
MAREL.AS Yearly EPS VS EstimatesMAREL.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

1

4. MAREL.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 227.50, which means the current valuation is very expensive for MAREL.
  • Compared to the rest of the industry, the Price/Earnings ratio of MAREL indicates a slightly more expensive valuation: MAREL is more expensive than 66.34% of the companies listed in the same industry.
  • MAREL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.60.
  • Based on the Price/Forward Earnings ratio of 29.78, the valuation of MAREL can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MAREL indicates a slightly more expensive valuation: MAREL is more expensive than 78.22% of the companies listed in the same industry.
  • MAREL is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 227.5
Fwd PE 29.78
MAREL.AS Price Earnings VS Forward Price EarningsMAREL.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • 75.25% of the companies in the same industry are cheaper than MAREL, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of MAREL indicates a slightly more expensive valuation: MAREL is more expensive than 67.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 67.72
EV/EBITDA 23.03
MAREL.AS Per share dataMAREL.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MAREL does not grow enough to justify the current Price/Earnings ratio.
  • MAREL's earnings are expected to grow with 39.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.03
PEG (5Y)N/A
EPS Next 2Y45.57%
EPS Next 3Y39%

2

5. MAREL.AS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.19%, MAREL is not a good candidate for dividend investing.
  • MAREL's Dividend Yield is comparable with the industry average which is at 1.60.
  • Compared to an average S&P500 Dividend Yield of 1.88, MAREL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

  • The dividend of MAREL decreases each year by -18.19%.
Dividend Growth(5Y)-18.19%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 54.39% of the earnings are spent on dividend by MAREL. This is a bit on the high side, but may be sustainable.
DP54.39%
EPS Next 2Y45.57%
EPS Next 3Y39%
MAREL.AS Yearly Income VS Free CF VS DividendMAREL.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M
MAREL.AS Dividend Payout.MAREL.AS Dividend Payout, showing the Payout Ratio.MAREL.AS Dividend Payout.PayoutRetained Earnings

MAREL.AS Fundamentals: All Metrics, Ratios and Statistics

Marel hf

AMS:MAREL (1/3/2025, 7:00:00 PM)

4.55

+0.12 (+2.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30
Earnings (Next)02-12
Inst Owners39.57%
Inst Owner ChangeN/A
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap3.51B
Revenue(TTM)1.66B
Net Income(TTM)11.40M
Analysts84
Price Target0.03 (-99.34%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Yearly Dividend0.02
Dividend Growth(5Y)-18.19%
DP54.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.24%
PT rev (3m)14.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)12.97%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-1.19%
Valuation
Industry RankSector Rank
PE 227.5
Fwd PE 29.78
P/S 2.11
P/FCF 67.72
P/OCF 34.36
P/B 3.39
P/tB N/A
EV/EBITDA 23.03
EPS(TTM)0.02
EY0.44%
EPS(NY)0.15
Fwd EY3.36%
FCF(TTM)0.07
FCFY1.48%
OCF(TTM)0.13
OCFY2.91%
SpS2.16
BVpS1.34
TBVpS-0.44
PEG (NY)5.03
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.1%
ROCE 4.33%
ROIC 3.55%
ROICexc 3.67%
ROICexgc 12.7%
OM 5.21%
PM (TTM) 0.69%
GM 36.06%
FCFM 3.12%
ROA(3y)2.73%
ROA(5y)3.95%
ROE(3y)6.07%
ROE(5y)8.09%
ROIC(3y)5.23%
ROIC(5y)6.94%
ROICexc(3y)5.48%
ROICexc(5y)7.75%
ROICexgc(3y)24.97%
ROICexgc(5y)39.54%
ROCE(3y)6.38%
ROCE(5y)8.46%
ROICexgc growth 3Y-34.3%
ROICexgc growth 5Y-33.18%
ROICexc growth 3Y-26.23%
ROICexc growth 5Y-21.39%
OM growth 3Y-23.73%
OM growth 5Y-17.24%
PM growth 3Y-39.86%
PM growth 5Y-29.33%
GM growth 3Y-2.31%
GM growth 5Y-2.35%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.84
Debt/FCF 17.03
Debt/EBITDA 4.63
Cap/Depr 49.7%
Cap/Sales 3.03%
Interest Coverage 1.43
Cash Conversion 54.34%
Profit Quality 454.39%
Current Ratio 1.36
Quick Ratio 0.77
Altman-Z 2.59
F-Score5
WACC5.55%
ROIC/WACC0.64
Cap/Depr(3y)100.26%
Cap/Depr(5y)91.26%
Cap/Sales(3y)5.13%
Cap/Sales(5y)4.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.06%
EPS 3Y-32.75%
EPS 5Y-25.45%
EPS Q2Q%-62.39%
EPS Next Y45.24%
EPS Next 2Y45.57%
EPS Next 3Y39%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.67%
Revenue growth 3Y11.62%
Revenue growth 5Y7.52%
Sales Q2Q%-4.14%
Revenue Next Year-0.68%
Revenue Next 2Y2.53%
Revenue Next 3Y3.66%
Revenue Next 5Y4.44%
EBIT growth 1Y-18.13%
EBIT growth 3Y-14.87%
EBIT growth 5Y-11.02%
EBIT Next Year83.77%
EBIT Next 3Y32.66%
EBIT Next 5Y29.2%
FCF growth 1Y333.33%
FCF growth 3Y-25.94%
FCF growth 5Y-13.88%
OCF growth 1Y47.33%
OCF growth 3Y-8.89%
OCF growth 5Y-3.71%

Marel hf / MAREL.AS Fundamental Analysis FAQ

What is the fundamental rating for MAREL stock?

ChartMill assigns a fundamental rating of 2 / 10 to MAREL.AS.


What is the valuation status for MAREL stock?

ChartMill assigns a valuation rating of 1 / 10 to Marel hf (MAREL.AS). This can be considered as Overvalued.


How profitable is Marel hf (MAREL.AS) stock?

Marel hf (MAREL.AS) has a profitability rating of 3 / 10.


How financially healthy is Marel hf?

The financial health rating of Marel hf (MAREL.AS) is 2 / 10.


Can you provide the expected EPS growth for MAREL stock?

The Earnings per Share (EPS) of Marel hf (MAREL.AS) is expected to grow by 45.24% in the next year.